Inventiva Stock Deutsche Boerse AG
Stocks
6IV
FR0013233012
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Deutsche Boerse AG
09:50:26 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 2.900 EUR | +1.40% |
|
-9.52% | -21.94% |
| 09-20 | Inventiva S.A.(ENXTPA:IVA) added to S&P Global BMI Index | CI |
| 09-16 | Inventiva S.A. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-15-2026 04:50 PM |
| Market Cap | 672M 766M 635M 579M 1.08B 73.42B 1.09B 7.6B 2.94B 37.51B 2.88B 2.81B 121B | P/E 2026 * |
-4.04x | P/E 2027 * | -3.64x |
|---|---|---|---|---|---|
| Enterprise Value | 553M 630M 522M 476M 891M 60.37B 897M 6.25B 2.42B 30.84B 2.36B 2.31B 99.12B | EV / Sales 2026 * |
81.3x | EV / Sales 2027 * | 0.98x |
| Free-Float |
89.08% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| IVA | Real-time | |
CBOE
| IVAp | Real-time | |
|
London S.E.
| 0RNK | Delayed | |
|
Xetra
| 6IV | Delayed | |
|
Börse Stuttgart
| 6IV | Delayed | |
|
Tradegate
| 6IV | Real-time | |
|
Boerse Muenchen
| 6IV | Real-time | |
|
Deutsche Boerse AG
| 6IV | Delayed | |
|
OTC Markets
| IVEVF | Delayed | |
|
CBOE
| 0RNK | Real-time |
Last Transcript: Inventiva
| 1 day | +1.40% | ||
| 1 week | -9.52% | ||
| Current month | -25.06% | ||
| 1 month | -26.68% | ||
| 3 months | +1.05% | ||
| 6 months | -42.00% | ||
| Current year | -21.94% |
| 1 week | 2.68 |  | 3.14 |
| 1 month | 2.68 | | 4.12 |
| Current year | 2.68 | | 5.81 |
| 1 year | 2.68 | | 5.81 |
| 3 years | 1.45 | | 5.81 |
| 5 years | 1.45 | | 12.92 |
| 10 years | 1.45 | | 15.58 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Obenshain
CEO | Chief Executive Officer | 53 | 2025-09-30 |
| Director of Finance/CFO | 59 | 2026-04-21 | |
| Chief Operating Officer | - | 2026-08-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Annick Schwebig
BRD | Director/Board Member | 76 | 2017-01-31 |
| Director/Board Member | 63 | 2019-05-26 | |
G. Turenne
BRD | Director/Board Member | 52 | 2024-04-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.40% | -9.52% | - | - | 766M | |
| -3.30% | +1.50% | +57.79% | +99.14% | 72.26B | |
| +1.25% | -3.01% | +37.83% | +87.66% | 60.24B | |
| +2.12% | +5.26% | +35.69% | +23.40% | 27.73B | |
| -3.06% | -1.81% | -14.01% | +357.24% | 25.74B | |
| -0.75% | +2.56% | +0.45% | -3.28% | 24.75B | |
| +0.40% | +0.75% | +23.72% | -11.33% | 20.74B | |
| -1.70% | -2.12% | +150.24% | +326.97% | 15.06B | |
| +0.36% | -0.34% | +48.98% | +167.40% | 14.42B | |
| +0.21% | +1.17% | -3.95% | +512.06% | 14.23B | |
| Average | -0.31% | +0.44% | +37.41% | +173.25% | 30.57B | |
| Weighted average by Cap. | -0.76% | +0.31% | +38.16% | +133.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.8M 7.75M 6.42M 5.85M 10.96M 743M 11.03M 76.85M 29.77M 379M 29.09M 28.47M 1.22B | 108M 123M 102M 92.63M 173M 11.75B 175M 1.22B 471M 6.01B 460M 451M 19.3B |
| Net income | -151M -172M -143M -130M -244M -16.52B -245M -1.71B -662M -8.44B -647M -633M -27.12B | -96.13M -110M -90.79M -82.74M -155M -10.5B -156M -1.09B -421M -5.36B -411M -402M -17.24B |
| Net Debt | -120M -136M -113M -103M -193M -13.05B -194M -1.35B -523M -6.67B -511M -500M -21.43B | -567M -646M -535M -488M -913M -61.91B -920M -6.41B -2.48B -31.63B -2.43B -2.37B -102B |
| Date | Price | Change |
|---|---|---|
| 26-09-25 | €2.900 | +1.40% |
| 26-09-24 | €2.860 | -3.87% |
| 26-09-23 | €2.975 | -2.14% |
| 26-09-22 | €3.040 | -3.18% |
| 26-09-21 | €3.140 | -2.03% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IVA Stock
- 6IV Stock
Select your edition
All financial news and data tailored to specific country editions
